(NYSE:IPG), New York, NY, Feb. 12, 2025 (GLOBE NEWSWIRE) — FOURTH QUARTER Total revenue, including billable expenses, was $2.9 billion Revenue before billable expenses (“net revenue”) was $2.4 billion, with organic decrease of -1.8% Reported net income was $344.5 million Adjusted EBITA before restructuring charges and deal costs was $591.2 million with margin of 24.3% […]
(NASDAQ:DENN), SPARTANBURG, S.C., Feb. 12, 2025 (GLOBE NEWSWIRE) — Denny's Corporation (the “Company”) (NASDAQ: DENN), owner and operator of Denny's Inc. (“Denny's”) and Keke's Inc. (“Keke's”) today reported results for its fourth quarter and full year ended December 25, 2024 and provided a business update on the Company's operations. Kelli Valade, Chief Executive Officer, stated,
(NASDAQ:INMB), Medical review of Phase 1 cohorts demonstrated no safety issues Data to be presented at the 10th Annual Innate Killer Summit, March 3-5 BOCA RATON, Fla, Feb. 12, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology and inflammation company, continues to advance its Natural Killer (NK) cell therapy,
(NASDAQ:MLYS), – Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 – – Completed enrollment in Explore-CKD Phase 2 trial and anticipate delivering topline data in Q2 2025 – – Initiating Phase 2 trial to evaluate lorundrostat for the treatment of patients
(NASDAQ:APTO),(TSX:APS), TUS+VEN+AZA triplet achieves Cycle 1 complete remission (CR) in TP53-mutated/CK AMLTUS+VEN+AZA triplet achieves Cycle 1 complete remissions in FLT3-wildtype AML patientsTUS+VEN+AZA triplet shows favorable safety with no alteration of VEN and AZA dosingPK levels of TUS in the triplet remain equivalent to levels as TUS or TUS+VEN therapy SAN DIEGO and TORONTO, Feb. 12,
(NASDAQ:LTBR), Figure 1: Lightbridge and INL teams at Idaho National Laboratory RESTON, Va., Feb. 12, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (Lightbridge) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced a significant milestone in its innovative nuclear fuel development efforts, successfully performing a co-extrusion demonstration of a coupon sample consisting of an alloy
(NASDAQ:BOOM), Steel Connect proposal undervalues DMC and denies stockholders participation in the Company's emerging value creation opportunity Fourth quarter sales and adjusted EBITDA expected to exceed high end of guidance range and demonstrate stabilization of the Company BROOMFIELD, Colo., Feb. 12, 2025 (GLOBE NEWSWIRE) — DMC Global Inc. (Nasdaq: BOOM) (“DMC” or the “Company”) today
(TSX:BLX), MONTREAL, Feb. 12, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) has declared a quarterly dividend of $0.165 per common share. This dividend will be paid on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. Boralex has
(NASDAQ:CHEF), RIDGEFIELD, Conn., Feb. 12, 2025 (GLOBE NEWSWIRE) — The Chefs' Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs'”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today reported financial results for its fourth quarter ended December 27, 2024. Financial highlights for the fourth quarter of 2024:
(NasdaqGM:LIEN),(NasdaqGM:REFI), NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company (“BDC”), today announced that the Company has closed a new $100 million senior secured revolving credit facility (the “Credit Facility”) led by an